Laguna Hills, CA – According to filings with the U.S. Securities and Exchange Commission, Adagio Medical is raising $42,500,017.00 in new funding. Sources indicate as part of senior management Chief Operating Officer, Hakon Bergheim played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Adagio Medical

Adagio Medical, Inc., a privately held medical device company located in Laguna Hills, California, is developing innovative cryoablation technologies that create continuous, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia. Adagio Medical, Inc. is a Fjord Ventures portfolio company.

To learn more about Adagio Medical, visit http://adagiomedical.com/

Contact:
Hakon Bergheim, Chief Operating Officer
949-348-1188
hbergheim@adagiomedical.com
https://www.linkedin.com/in/hakonbergheim/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved